Strides gets USFDA nod for generic Oxybutynin Chloride tablets

Company's step-down wholly owned subsidiary Strides Pharma Global Pte Ltd, Singapore, has received approval for Oxybutynin Chloride Tablets USP, 5 mg from the United States Food & Drug Administration (USFDA), Strides said in a filing to BSE.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3p3k0Sd
via IFTTT

0 comments:

Post a Comment